Analysis of specific metabolite profiling of minimal hepatic encephalopathy based on metabolomics analytical platforms of GC-TOFMS and UPLC-QTOFMS
-
摘要:
目的分析对比健康志愿者及轻微型肝性脑病(MHE)患者的血清代谢物谱,确立MHE特异性生物标志物,探索MHE早期诊断方法。方法收集2013年10月-2014年10月广西中医药大学第一附属医院收治的乙型肝炎肝硬化导致的MHE患者29例(MHE组)和同期本院健康体检者50例(NC组),运用气相色谱-飞行时间质谱仪(GC-TOFMS)和超高压液相色谱-四级杆-飞行时间质谱仪(UPLC-QTOFMS)检测受试者血清样本中的代谢物,并通过主成分分析(PCA)、正交偏最小二乘法-判别分析(OPLS-DA)进行多维统计分析,结合单维t检验进行组间比较,最终确定与MHE相关的生物标志物。结果对2组进行了PCA和OPLS-DA建模分析,结合单维t检验结果,并参照模型中的VIP值,在2组血清中找到27种可能的MHE特异性生物标志物。根据OPLS-DA模型中MHE组和NC组代谢物质的比值可见,与健康志愿者相比,在MHE患者血清中下调的物质有9种,上调的物质有18种。结论基于GC-TOFMS和UPLC-QTOFMS平台的血清代谢组学分析技术可同时检测患者血清中多种代谢物质,有助于研究MHE的发病机制。本研究建立...
Abstract:Objective To analyze and compare the serum metabolite profiling of healthy volunteers and patients with minimal hepatic encephalopathy( MHE),identify the specific biomarkers of MHE,and explore the method for early diagnosis of MHE. Methods Twenty-nine patients with MHE caused by hepatitis B cirrhosis who were admitted to First Affiliated Hospital of Guangxi University of Chinese Medicine( MHE group) from October 2013 to October 2014,as well as 50 healthy volunteers who received physical examinations in this hospital( NC group) during the same period,were collected. Gas chromatography and time- of- flight mass spectrometry( GC- TOFMS) and ultra- high- pressure liquid chromatography- quadrupole- time- of- flight mass spectrometry( UPLC- QTOFMS) were applied to determine the metabolites in serum samples. Principal component analysis( PCA) and orthogonal partial least squares- discriminant analysis( OPLS-DA) were applied for multivariate statistical analysis,and univariate t test was applied for comparison between the two groups,so as to determine the biomarkers for MHE. Results In combination of the modeling analysis with PCA and OPLS- DA,the results from univariate t test,and vasoactive intestinal peptide( VIP) value in the models,a total of 27 possible specific biomarkers for MHE were found in serum in the two groups. According to the fold change between MHE group and NC group in OPLS- DA model,there were 9 down- regulated metabolites and 18 up- regulated metabolites in the patients with MHE compared with healthy volunteers. Conclusion Serum metabolomics analytical platforms such as GC- TOFMS and UPLC- QTOFMS can detect a variety of metabolites in serum,which can be of help to explore the pathogenesis of MHE. In addition,the diagnostic model OPLS- DA established in this study can differentiate between the normal population and patients with MHE,which may be applied for early diagnosis of MHE.
-
Key words:
- hepatic encephalopathy /
- mass spectrometry /
- early diagnosis
-
[1] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ. [2]LIU CH,WEI BH,YAO SK.Clinic consensus of cirrhosis of integrative medicine[J].Chin J Integr Trad West Med Dig,2011,19(4):277-279.(in Chinese)刘成海,危北海,姚树坤.肝硬化中西医结合诊疗共识[J].中国中西医结合消化杂志,2011,19(4):277-279. [3]Chinese Society of Gastroenterology and Chinese Society of Hepatology,Chinese Medical Association.Consensus on the diagnosis and treatment of hepatic encephalopathy in China(Chongqing,2013)[J/CD].Chin J Front Med Sci:Electronic Version,2014,6(2):81-93.(in Chinese)中华医学会消化病学分会,中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013年,重庆)[J/CD].中国医学前沿杂志:电子版,2014,6(2):81-93. [4]STENLUND H,GORZSS A,PERSSON P,et al.Orthogonal projections to latent structures discriminant analysis modeling on in situ FT-IR spectral imaging of liver tissue for identifying sources of variability.[J]Anal Chem,2008,80(18):6898-6906. [5]WEISSENBORN K.Psychometric tests for diagnosing minimal hepatic encephalopathy[J].Metab Brain Dis,2013,28(2):227-229. [6]ADROVER R,BARRIO M,ALBUQUERQUE M,et al.Validation of the number connection test for identifying patients with minimal hepatic encephalopathy[J].Acta Gastroenterol Latinoam,2012,42(2):105-111. [7]QI JX.Research on minimal hepatic encephalopathy metabonomics[D].Dalian:Dalian Med Univ,2013.(in Chinese)齐俊霞.轻微肝性脑病代谢组学的研究[D].大连:大连医科大学,2013. [8]ZHU J.Study of syndrome of damp-heat exuberant of HBV induced acute-on-chronic and subacute-on-chronic liver failure based on metabonomics[D].Wuhan:Hubei Tradit Chin Med Univ,2013.(in Chinese)朱洁.基于代谢组学的慢加急(亚急)性乙肝肝衰竭湿热证的证候研究[D].武汉:湖北中医药大学,2013. [9]YANG LN,WEN J,SUN Y,et al.Metabonomic study on the anti-liver injury effect of Si-Ni-San on rats by using UPLC-MS/MS[J].Acta Pharm Sin,2014,49(3):368-373.(in Chinese)杨丽娜,温静,孙毅,等.四逆散抗肝损伤作用的大鼠血清UPLC-MS/MS代谢组学研究[J].药学学报,2014,49(3):368-373. [10]GENG F,ZHANG N,FANG H,et al.Metabonomic study on protective effect of xiaoyao powder for acute hepatic injury in rats[J].J Chin Med Materls,2014,37(2):275-279.(in Chinese)耿放,张宁,方衡,等.逍遥散对急性肝损伤大鼠模型保护作用的代谢组学研究[J].中药材,2014,37(2):275-279. [11]YANG T,LIU CH.Exploration on mechanism of different therapeutic effects of fuzheng huayu formula on different patients with liver fibrosis from the aspect of metabonomics[J].World Chin Med,2014,9(5):549-552,556.(in Chinese)杨涛,刘成海.基于代谢组学的扶正化瘀方抗肝纤维化差异疗效机制研究探讨[J].世界中医药,2014,9(5):549-552,556. [12]HUANG Y.The serum metabolic profiling on different differentiation of HCC patients[D].Tianjin:Tianiin Med Univ,2014.(in Chinese)黄娅.不同分化程度肝细胞肝癌患者血清代谢轮廓分析[D].天津:天津医科大学,2014. [13]LI XF.Metabolomics study of HBV-induced acute-on-chronic liver failure,chronic liver failure and pre-acute-on-chronic liver failure[D].Hangzhou:Zhejiang Univ,2014.(in Chinese)李小芬.乙肝慢加急性肝衰竭与慢性肝衰竭、肝衰竭前期血清代谢组学初步研究[D].杭州:浙江大学,2014. [14]QI SW.Study on serum metabolic profiling in different stage of liver cirrhosis patients with hepatitis b virus infection[D].Chongqing:Chongqing Med Univ,2012.(in Chinese)齐素文.HBV肝硬化不同阶段血清代谢物组的研究[D].重庆:重庆医科大学,2012. [15]XIE W,YAO C,YAO F,et al.Experimental study on minimal hepatic encephalopathy with LC-MS[J].Shanxi J Tradit Chin Med,2012,28(3):46-48.(in Chinese)谢武,姚春,姚凡,等.基于液相色谱-质谱(LC-MS)技术对轻微型肝性脑病的实验研究[J].山西中医,2012,28(3):46-48. [16]KWONG E,LI Y,HYLEMON PB,et al.Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism[J].Acta Pharmaceutica Sinica B,2015,5(2):151-157. [17]DISTRUTTI E,SANTUCCI L,CIPRIANI S,et al.Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa[J].J Gastroenterology,2015,50(7):1-13.
计量
- 文章访问数: 2253
- HTML全文浏览量: 41
- PDF下载量: 448
- 被引次数: 0